Arteris, Inc. (NASDAQ:AIP) Short Interest Update

Arteris, Inc. (NASDAQ:AIP) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 391,100 shares, a decline of 23.3% from the November 15th total of 509,900 shares. Based on an average daily trading volume, of 111,700 shares, the short-interest ratio is currently 3.5 days. Approximately 1.6% of the company’s shares are sold short.

Analyst Ratings Changes

Separately, Rosenblatt Securities reissued a “buy” rating and issued a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.

Insider Buying and Selling at Arteris

In other Arteris news, CEO K Charles Janac sold 17,856 shares of the stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72. Following the completion of the sale, the chief executive officer now directly owns 10,287,435 shares in the company, valued at approximately $104,108,842.20. This trade represents a 0.17 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Paul L. Alpern sold 3,615 shares of the business’s stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $7.13, for a total value of $25,774.95. Following the completion of the transaction, the vice president now directly owns 68,084 shares in the company, valued at $485,438.92. This represents a 5.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 92,717 shares of company stock worth $791,369. Insiders own 33.70% of the company’s stock.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AIP. Vanguard Group Inc. increased its stake in Arteris by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company’s stock valued at $8,390,000 after purchasing an additional 3,242 shares in the last quarter. US Bancorp DE acquired a new position in shares of Arteris during the third quarter valued at about $34,000. Renaissance Technologies LLC increased its position in shares of Arteris by 6.1% during the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after acquiring an additional 6,600 shares in the last quarter. MetLife Investment Management LLC raised its holdings in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares during the last quarter. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of Arteris in the 2nd quarter worth about $86,000. 64.36% of the stock is owned by institutional investors.

Arteris Trading Up 1.5 %

AIP opened at $10.29 on Friday. The company has a fifty day moving average price of $8.00 and a two-hundred day moving average price of $7.83. Arteris has a 1-year low of $4.83 and a 1-year high of $10.60. The company has a market cap of $413.45 million, a P/E ratio of -10.72 and a beta of 1.25. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.